These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 17599456)

  • 1. Treating hypercholesterolemia and hypertension based on lifetime global risk.
    Kostis JB
    Am J Cardiol; 2007 Jul; 100(1):138-42. PubMed ID: 17599456
    [No Abstract]   [Full Text] [Related]  

  • 2. [European Hypertension Congress initiative: implement modern risk management without further delay!].
    Aumiller J
    MMW Fortschr Med; 2005 Sep; 147(38):39, 41-2. PubMed ID: 16218227
    [No Abstract]   [Full Text] [Related]  

  • 3. ALLHAT: the largest and most important clinical trial in hypertension ever done in the USA. Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial.
    Elliott WJ
    Am J Hypertens; 1996 Apr; 9(4 Pt 1):409-11. PubMed ID: 8722446
    [No Abstract]   [Full Text] [Related]  

  • 4. [Cardiovascular prevention: not necessary under the age of 40].
    Walma EP
    Ned Tijdschr Geneeskd; 2009; 153():B351. PubMed ID: 19785804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [CBO guideline 'high blood pressure' (revision)].
    de Bruijckere PA
    Ned Tijdschr Geneeskd; 2002 Mar; 146(9):439; author reply 439. PubMed ID: 11901947
    [No Abstract]   [Full Text] [Related]  

  • 6. Guidelines for antihypertensive therapy: problems with a strategy based on absolute cardiovascular risk, reply to comments.
    Simpson FO
    J Hypertens; 1997 Jan; 15(1):1-2. PubMed ID: 9050964
    [No Abstract]   [Full Text] [Related]  

  • 7. [CBO guideline 'high blood pressure' (revision)].
    Polak BC
    Ned Tijdschr Geneeskd; 2002 Mar; 146(9):439; author reply 439-40. PubMed ID: 11901948
    [No Abstract]   [Full Text] [Related]  

  • 8. Cardiovascular prevention (VI). Use of drugs in the primary prevention of arterial hypertension and dyslipidemia.
    González-Juanatey JR; Mazón Ramos P
    Rev Esp Cardiol; 2008 Aug; 61(8):861-79. PubMed ID: 18684369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The 2007 ESH/ESC guidelines for the management of arterial hypertension.
    Bonny A; Lacombe F; Yitemben M; Discazeaux B; Donetti J; Fahri P; Megbemado R; Estampes B
    J Hypertens; 2008 Apr; 26(4):825; author reply 825-6. PubMed ID: 18327095
    [No Abstract]   [Full Text] [Related]  

  • 10. [Monitoring drug adherence for hypertensive and dyslipidemic patients in networks of community-based pharmacists and physicians].
    Santschi V; Rodondi N; Bugnon O; Pannatier A; Burnier M
    Rev Med Suisse; 2008 Sep; 4(170):1928, 1930-2, 1934 passim. PubMed ID: 18847122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hypercholesterolemia: when and how much to treat it?].
    Carmena R
    Med Clin (Barc); 1983 Feb; 80(6):261-2. PubMed ID: 6865558
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of hypertension in Finnish general practice seems unsatisfactory despite evidence-based guidelines.
    Varis J; Savola H; Vesalainen R; Kantola I
    Blood Press; 2009; 18(1-2):62-7. PubMed ID: 19353413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hypolipemic treatment in pre- and postmenopausal women].
    Ferreira Aguar A; Casasnovas Lenguas JA; Ferreira Montero IJ
    Rev Esp Cardiol; 1994; 47 Suppl 3():27-31. PubMed ID: 7816977
    [No Abstract]   [Full Text] [Related]  

  • 14. Coronary heart disease risk factors and antihypertensive drug selection.
    Kaplan NM
    J Cardiovasc Pharmacol; 1982; 4 Suppl 2():S187-9. PubMed ID: 6177954
    [No Abstract]   [Full Text] [Related]  

  • 15. Differences in antihypertensive compliance by BCBSRI disease and case management intervention group.
    Kuo S; Burrill J
    Med Health R I; 2007 Dec; 90(12):381-4. PubMed ID: 18314829
    [No Abstract]   [Full Text] [Related]  

  • 16. [What should be the role of antilipemic agents in the control of hypercholesterolemia in elderly persons?].
    Champoux N; Latour J
    Union Med Can; 1994 Feb; 123(2):91-4. PubMed ID: 8203037
    [No Abstract]   [Full Text] [Related]  

  • 17. The design of ALLHAT may have biased the study's outcome in favor of the diuretic cohort.
    Hebert LA; Rovin BH; Hebert CJ
    Nat Clin Pract Nephrol; 2007 Feb; 3(2):60-1. PubMed ID: 17251990
    [No Abstract]   [Full Text] [Related]  

  • 18. Sex differences in risk factor control of treated hypertensives: a national primary healthcare-based study in Sweden.
    Journath G; Hellénius ML; Petersson U; Theobald H; Nilsson PM;
    Eur J Cardiovasc Prev Rehabil; 2008 Jun; 15(3):258-62. PubMed ID: 18525379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk and disease.
    Schwartz PH
    Perspect Biol Med; 2008; 51(3):320-34. PubMed ID: 18723938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypertension strategies in the third millennium: conservatism, evidence and the folly of speculation.
    McIntyre HF
    Int J Clin Pract; 2009 Jan; 63(1):7-14. PubMed ID: 19125987
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.